Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Adamis Pharmaceuticl (ADMP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Latest Headlines for [[ item.sessionDateDisplayLong ]]
Adamis Pharmaceuticals Announces FDA Acceptance for Review for the Supplemental New Drug Application of Its Low Dose Symjepi Product Candidate

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) ("Company" or "Adamis") today announced that the U.S. Food and Drug Administration ("FDA") has accepted for review the Company's supplemental New Drug Application...

ADMP : 2.95 (-5.75%)
Report: Exploring Fundamental Drivers Behind Vector Group, NovoCure, ORBCOMM, Adamis Pharmaceuticals, Calumet Specialty Products Partners, and Lakeland -- New Horizons, Emerging Trends, and Upcoming Developments

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Vector Group Ltd. (NYSE:VGR),...

VGR : 20.36 (+1.19%)
ORBC : 11.00 (+0.73%)
NVCR : 21.80 (+3.56%)
ADMP : 2.95 (-5.75%)
LBAI : 20.20 (+2.02%)
CLMT : 7.25 (+1.40%)
US Compounding, a Subsidiary of Adamis Pharmaceuticals, Develops a Unique Compound to Manage Ulcers in Horses

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) ("Adamis") today announced that its subsidiary, US Compounding, has developed a unique compound to manage ulcers in horses. Ulcers are common in the majority...

ADMP : 2.95 (-5.75%)
Today's Research Reports on Stocks to Watch: Revance Therapeutics and Adamis Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / December 6, 2017 / Shares of Revance headed higher on Tuesday after announcing successful results in a pair of phase 3 clinical trials that are evaluating its RT002 treatment...

ADMP : 2.95 (-5.75%)
RVNC : 31.35 (+3.64%)
Adamis Pharmaceuticals Announces Presentation of Results of a Human Factors Study Conducted With Its Newly Approved Epinephrine Pre-filled Syringe at the American Academy of Allergy, Asthma and Immunology (AAAAI) Joint Congress With the World Allergy Organization

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) ("Adamis") announced today the acceptance of a presentation entitled "Human Factors Study of A Newly Approved Epinephrine Prefilled Syringe (Symjepi) for...

ADMP : 2.95 (-5.75%)
Adamis Pharmaceuticals Submits Prior Approval Supplement to FDA for the Pediatric Version of Symjepi

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) today announced the submission of a prior approval supplement to the U.S. Food and Drug Administration ("FDA") for a pediatric version (0.15mg) of Symjepi(TM)....

ADMP : 2.95 (-5.75%)
Global Biotechnology Market Showing Potential for Further Growth

According to a report by Global Market Insights, Inc., the Biotechnology Market size will exceed USD 775.2 billion with 9.9% CAGR from 2016 to 2024. Based on technology, the industry is segmented into...

ADMP : 2.95 (-5.75%)
COSM : 10.4000 (-5.20%)
INFI : 1.89 (+2.16%)
CASI : 3.74 (-1.06%)
PLX : 0.68 (+1.49%)
Recent Analysis Shows Universal Display, Adamis Pharmaceuticals, Calumet Specialty Products Partners, Eldorado Resorts, PHH, and MRC Global Market Influences -- Renewed Outlook, Key Drivers of Growth

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Universal Display Corporation...

PHH : 8.76 (+2.58%)
ADMP : 2.95 (-5.75%)
OLED : 160.05 (-0.65%)
ERI : 32.85 (-3.81%)
CLMT : 7.25 (+1.40%)
MRC : 16.88 (+2.24%)
Stock Performance Review on Drug Delivery Industry -- Adamis Pharma, Alkermes, PetMed Express, and Valeant Pharma

If you want a Stock Review on ADMP, ALKS, PETS, or VRX then come over to http://dailystocktracker.com/register/ and sign up for your free customized report. On Wednesday, the NASDAQ Composite ended the...

PETS : 47.68 (+4.36%)
ADMP : 2.95 (-5.75%)
ALKS : 65.67 (+1.42%)
VRX : 18.90 (+1.72%)
Technical Snapshots for these Drug Delivery Stocks -- Delcath Systems, Valeant Pharma, PetMed Express, and Adamis Pharma

If you want a Stock Review on DCTH, VRX, PETS, or ADMP then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. The market for Drug Delivery technology...

VRX.TO : 23.91 (+1.83%)
PETS : 47.68 (+4.36%)
ADMP : 2.95 (-5.75%)
DCTH : 0.0200 (+3.09%)
VRX : 18.90 (+1.72%)
Why Have Mylan's (MYL) Shares Lost 19.4% So Far This Year?

Shares of Mylan N.V. (MYL) have lost almost 19.4% in the year so far given the competitive pressure.

MYL : 41.93 (+1.43%)
ADMP : 2.95 (-5.75%)
NVS : 85.99 (+0.73%)
GSK : 37.61 (+0.75%)
Today's Research Reports on Stocks to Watch: Adamis Pharmaceuticals and Mylan

NEW YORK, NY / ACCESSWIRE / August 14, 2017 / While shares of Mylan continued to suffer last Friday, competitor Adamis Pharmaceuticals saw gains. Adamis has an Epinephrine injection that is a generic...

MYL : 41.93 (+1.43%)
ADMP : 2.95 (-5.75%)
Technical Reports on Drug Delivery Equities -- PetMed Express, Adamis Pharma, Delcath Systems, and Alkermes

If you want a Stock Review on PETS, ADMP, DCTH or ALKS then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. Today's research on DailyStockTracker.com...

PETS : 47.68 (+4.36%)
ADMP : 2.95 (-5.75%)
DCTH : 0.0200 (+3.09%)
ALKS : 65.67 (+1.42%)
Business Highlights

___

YHOO : 123.47 (unch)
ADMP : 2.95 (-5.75%)
AMZN : 1,498.23 (+2.03%)
WFM : 42.00 (+0.02%)
Adamis Gets FDA Nod for Generic Version of Mylan's EpiPen

Shares of Adamis Pharmaceuticals Corporation (ADMP) soared more than 50% after the FDA approved the company's Epinephrine injection, USP, (0.3 mg Pre-filled single dose syringe) which is the generic version...

MYL : 41.93 (+1.43%)
CVS : 69.79 (-1.23%)
ADMP : 2.95 (-5.75%)
IPXL : 20.50 (+4.06%)
Biotech Industry Showing Signs of a Revival in 2017: Today's Research on Adamis Pharmaceuticals and Arena Pharmaceuticals

NEW YORK, NY / ACCESSWIRE / June 16, 2017 / The Biotech Industry has continued to outperform the broader markets till now in 2017. Biotech companies appear to be benefiting from a speedier FDA approval...

ADMP : 2.95 (-5.75%)
ARNA : 41.81 (+3.18%)
XBI : 93.13 (+2.53%)
FDA approves new, cheaper rival to EpiPen allergy shot

TRENTON, N.J. (AP) — U.S. regulators have approved new competition for EpiPen, the emergency allergy medicine that made Mylan a poster child for pharmaceutical company greed.

ADMP : 2.95 (-5.75%)
Research Reports Coverage on Drug Delivery Stocks -- Valeant Pharma, Delcath Systems, Alkermes, and Adamis Pharma

This morning, Stock-Callers.com takes a closer look at Valeant Pharmaceuticals International Inc. (NYSE: VRX), Delcath Systems Inc. (NASDAQ: DCTH), Alkermes PLC (NASDAQ: ALKS), and Adamis Pharmaceuticals...

VRX.TO : 23.91 (+1.83%)
ADMP : 2.95 (-5.75%)
DCTH : 0.0200 (+3.09%)
VRX : 18.90 (+1.72%)
ALKS : 65.67 (+1.42%)
Adamis Pharmaceuticals Announces Closing of Public Offering of Common Stock and Exercise of Over-Allotment Option in Full

Adamis Pharmaceuticals Corporation (NASDAQ:ADMP), a specialty biopharmaceutical company focused on developing and commercializing products in the therapeutic areas of respiratory disease and allergy, announced...

ADMP : 2.95 (-5.75%)
Blog Coverage: Valeant Announces the Pricing for SILIQ as the Lowest Priced Injectable Biologic for Moderate-To-Severe Plaque Psoriasis

Upcoming AWS Coverage on Adamis Pharmaceuticals Post-Earnings Results

VRX.TO : 23.91 (+1.83%)
ADMP : 2.95 (-5.75%)
VRX : 18.90 (+1.72%)

Van Meerten Stock Picks

Nvidia - My Favorite S\&P 500 Large Cap Stock
$NVDA Summary96% technical by signals.
NVDA -3.11
Jim Van Meerten uses Barchart's tools to offer daily stock picks and recommendations. His portfolios have been honored by Marketocracy and Morningstar.

Barchart Morning Call

OVERNIGHT MARKETS AND NEWS Mar E-mini S&Ps ( ESH18 unch) this morning are down -0.05% and European stocks are down -0.57% after European manufacturing activity slowed more than expected this month. Losses were contained as the 10-year... Read More

Chart of the Day

Match Group Inc CS (MTCH)

Match Group (MTCH) is the Barchart Chart of the Day.  The popular on-line dating company has a Trend Spotter buy signal, a Weighted Alpha of 190.79+ and gained 152.84% in the last year.
Read More

Brugler Ag Report

Today's Commentary

Corn futures are showing fractional gains at Wednesday’s midday. The weekly EIA report will be delayed until Thursday morning, due to Monday’s holiday. Ahead of the USDA Ag Outlook Forum, a Reuters survey of analysts shows expectations fo...
Read More

Alan Brugler writes this daily agricultural markets overview with opening, midday and closing comments directed at the gain and meat Ag markets.

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.